NCT04990258A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC

N/A

Adalimumab

Rheumatoid Arthritis

N/A

Clinical Trials (1)

NCT05427942Yuflyma® (Adalimumab), Patient Experience After Switching

N/A

A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea

Essential Hypertension

N/A

Clinical Trials (1)

NCT04470830A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea

N/A

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ulcerative Colitis (UC)

N/A

Clinical Trials (1)

NCT07237516Zymfentra (Infliximab-dyyb) REal World Cohort STudy

N/A

L04RD1

Healthy

Phase 1

Clinical Trials (1)

NCT05568121A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers

Phase 1

CT-P13

Crohn's Disease

Phase 1

Clinical Trials (1)

NCT02883452A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Phase 1

CT-P17

Healthy

Phase 1

Clinical Trials (1)

NCT04295356To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17

Phase 1

Infliximab

Ankylosing Spondylitis

Phase 1

Clinical Trials (1)

NCT01220518Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)

Phase 1

CT-L01 12.5/1,000 mg

Healthy

Phase 1

Clinical Trials (1)

NCT05364164A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers

Phase 1

CT-P55

Healthy Male Subjects

Phase 1

Clinical Trials (1)

NCT07054970To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects

Phase 1

CT-P17

Healthy

Phase 1

Clinical Trials (1)

NCT03970824To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects

Phase 1

CT-P13 SC Auto-injector

Health, Subjective

Phase 1

Clinical Trials (1)

NCT03446976CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

Phase 1

CT-P59

SARS-CoV-2 Infection

Phase 1

Clinical Trials (1)

NCT04593641This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

Phase 1

CT-P63

SARS-CoV-2 Infection

Phase 1

Clinical Trials (1)

NCT05017168To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

Phase 1

CT-L01 12.5/500 mg

Healthy

Phase 1

Clinical Trials (1)

NCT05363592A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers

Phase 1

L03RD1

Type 2 Diabetes Mellitus (T2DM)

Phase 1

Clinical Trials (1)

NCT07158346Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers

Phase 1

CTL0801

Health, Subjective

Phase 1

Clinical Trials (1)

NCT05002244A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

Phase 1

CT-P43

Healthy Male Subjects

Phase 1

Clinical Trials (1)

NCT06951828A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects

Phase 1

CT-P43

Healthy Subjects

Phase 1

Clinical Trials (1)

NCT04428814Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Phase 1

CT-G20

Cardiomyopathy, Hypertrophic Obstructive

Phase 1

Clinical Trials (1)

NCT04418297A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Phase 1

CT-P16

Healthy

Phase 1

Clinical Trials (1)

NCT03247673To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Phase 1

CT-L01

Healthy

Phase 1

Clinical Trials (1)

NCT05363384A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers

Phase 1

Infliximab

Ankylosing Spondylitis

Phase 1

Clinical Trials (1)

NCT01571206An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1

Phase 1

CT-P47

Healthy Subjects

Phase 1

Clinical Trials (1)

NCT05617183Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

Phase 1

rituximab

Rheumatoid Arthritis

Phase 1

Clinical Trials (1)

NCT01534884Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis

Phase 1

L04RD1

Essential Hypertension

Phase 1

Clinical Trials (1)

NCT05993806A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

Phase 1

CT-P39

Healthy

Phase 1

Clinical Trials (1)

NCT04018313To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects

Phase 1

CT-P47

Healthy Subjects

Phase 1

Clinical Trials (1)

NCT05188378A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Phase 1

CT-P41

Healthy Male Subjects

Phase 1

Clinical Trials (1)

NCT04512872A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

Phase 1

CTL02

Healthy

Phase 1

Clinical Trials (1)

NCT07128654A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers

Phase 1

CT-P6 SC

Healthy

Phase 1

Clinical Trials (1)

NCT06687928To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)

Phase 1

Rituximab, MTX, folic acid

Rheumatoid Arthritis

Phase 1

Clinical Trials (1)

NCT01873443Long-Term Efficacy and Safety of CT-P10 in Patients With RA

Phase 1

CT-P59

SARS-CoV-2 Infection

Phase 1

Clinical Trials (1)

NCT04525079To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

Phase 1

rituximab

Diffuse Large B-Cell Lymphoma

Phase 1

Clinical Trials (1)

NCT01534949Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial

Phase 1

CT-G11

Healthy

Phase 1

Clinical Trials (1)

NCT03918967Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

Phase 1

CT-P52

Healthy Male Subjects

Phase 1

Clinical Trials (1)

NCT07367958A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects